121 results match your criteria: "Hospital for Skin and Venereal Diseases[Affiliation]"

Number of melanoma deaths over time in relation to tumour thickness: Data from a Melanoma Unit Reference Center.

J Eur Acad Dermatol Venereol

November 2024

1st Department of Dermatology and Venereology, School of Medicine, National and Kapodistrian University of Athens, "Andreas Syggros" Hospital for Skin and Venereal Diseases, Athens, Greece.

View Article and Find Full Text PDF

Topical therapy remains a critical component in the management of immune‑mediated inflammatory dermatoses such as psoriasis and atopic dermatitis. In this field, macrolactam immunomodulators, including calcineurin and mammalian target of rapamycin inhibitors, can offer steroid‑free therapeutic alternatives. Despite their potential for skin‑selective treatment compared with topical corticosteroids, the physicochemical properties of these compounds, such as high lipophilicity and large molecular size, do not meet the criteria for efficient penetration into the skin, especially with conventional topical vehicles.

View Article and Find Full Text PDF

We present a case of a 75-year-old male patient who experienced a severe exacerbation of his Kaposi sarcoma lesions, which have remained clinically stable for a year, following treatment with BRAF/mitogen-activated protein kinase inhibitors for his coexisting melanoma. In this case, we present the possibility that BRAF/MEK inhibition may be mechanistically associated with the progression of Kaposi sarcoma and briefly discuss the potential mechanisms behind this phenomenon.

View Article and Find Full Text PDF
Article Synopsis
  • Bimekizumab is a monoclonal antibody that targets interleukin-17A and interleukin-17F, proving to be very effective for treating chronic plaque psoriasis with a quick impact based on Randomized Controlled Trials (RCTs).
  • A study in Athens involved 61 patients with moderate-to-severe psoriasis, revealing that a significant percentage achieved marked improvement (PASI75: 65.7%, PASI90: 45.7%, PASI100: 32.4%) after just 4 weeks and even higher rates after 16 weeks.
  • The safety profile showed a few mild-to-moderate adverse events, including oral candidiasis, aligning with
View Article and Find Full Text PDF
Article Synopsis
  • Inconsistent reporting of outcomes in rosacea clinical trials is hindering accurate data analysis and meta-analyses, highlighting the need for standardized outcome measures.
  • A core outcome set (COS) was developed through systematic literature reviews and a Delphi process, involving feedback from physicians and patients to identify essential outcomes in rosacea trials.
  • The final COS includes 8 key domains, such as skin symptoms and patient satisfaction, which aim to enhance the comparability and relevance of future rosacea research and interventions.
View Article and Find Full Text PDF
Article Synopsis
  • * A survey was conducted with 490 Italian and 234 Greek dermatologists using a 50-item questionnaire to assess current practices in diagnosing and treating AA.
  • * Findings show that most dermatologists rely on patient history and clinical exams for diagnosis, use few quality-of-life assessments, and mainly prescribe topical steroids, revealing a wide variety in treatment approaches.
View Article and Find Full Text PDF

Five-Membered Nitrogen Heterocycles Angiotensin-Converting Enzyme (ACE) Inhibitors Induced Angioedema: An Underdiagnosed Condition.

Pharmaceuticals (Basel)

March 2024

Allergy Unit, 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, University General Hospital 'Attikon', 12462 Athens, Greece.

Angiotensin-converting enzyme (ACE) inhibitors are used primarily in the treatment of hypertension, heart failure, and in the acute phase of myocardial infarction. Lisinopril [N-[(1S)-1-car-boxy-3-phenylpropyl]-L-lysyl-L-proline], enalapril [(S)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline] and ramipril [2-aza-bicyclo-[3.3.

View Article and Find Full Text PDF

Background: Tuberculosis has a major global impact. Immunocompetent hosts usually control this disease, resulting in an asymptomatic latent tuberculosis infection (LTBI). Because TNF inhibitors increase the risk of tuberculosis reactivation, current guidelines recommend tuberculosis screening before starting any biologic drug, and chemoprophylaxis if LTBI is diagnosed.

View Article and Find Full Text PDF

Mass population movements have altered the epidemiology of tinea capitis (TC) in countries receiving refugees. Periodic monitoring of the local pathogen profiles may serve as a basis for both the selection of appropriate empirical antifungal therapy and the implementation of preventive actions. Therefore, we investigated the impact of an unprecedented immigration wave occurring in Greece since 2015 on the epidemiological trends of TC.

View Article and Find Full Text PDF

Introduction: Melanoma of the lentigo maligna (LM) type is challenging. There is lack of consensus on the optimal diagnosis, treatment, and follow-up.

Objectives: To obtain general consensus on the diagnosis, treatment, and follow-up for LM.

View Article and Find Full Text PDF

In May 2022, for the first time, multiple cases of mpox were reported in several non-endemic countries. The first ever case of the disease in Greece was confirmed on 8 June 2022, and a total of 88 cases were reported in the country until the end of April 2023. A multidisciplinary response team was established by the Greek National Public Health Organization (EODY) to monitor and manage the situation.

View Article and Find Full Text PDF

Background: Carbapenem-resistant (CRPA) is a life-threatening healthcare-associated infection affecting especially patients with immunosuppression and comorbidities. We investigated the association between the incidence of CRPA bacteremia, antibiotic consumption, and infection control measures in a hospital during 2013-2018.

Methods: We prospectively recorded the incidence of CRPA bacteremia, antibiotic consumption, use of hand-hygiene solutions, and isolation rates of multidrug-resistant (MDR) carrier patients.

View Article and Find Full Text PDF

Background: Limited data on immune checkpoint inhibitor (ICI)-induced pruritus per se and efficacy of different therapeutic modalities in its management exist.

Objective: To study the quantitative and qualitative characteristics of ICI-induced pruritus per se and to assess the efficacy of the therapeutic modalities usually applied.

Methods: We retrospectively reviewed the records of 91 patients who were under treatment with ICIs for any kind of neoplasia and developed pruritus during treatment.

View Article and Find Full Text PDF

Simultaneous Multiple-Stages Mpox Genital Lesions on the Same Site in a Traveler to Greece: A Case Report.

Vaccines (Basel)

April 2023

1st Department of Dermatology and Venereology, Athens Medical School, "Andreas Syggros" Hospital for Skin and Venereal Diseases, National and Kapodistrian University, 15772 Athens, Greece.

Article Synopsis
  • A 47-year-old Caucasian male traveler from an mpox-endemic region presented with a recent skin rash limited to his genital area, featuring distinct papules, vesicles, and pustules.
  • The rash showed multiple stages of lesions at the same site, which is an uncommon clinical presentation.
  • The patient exhibited symptoms like fever, fatigue, and a blood-tinged cough, leading to a suspicion of mpox, later confirmed as a West African clade non-variola orthopox virus through PCR testing.
View Article and Find Full Text PDF